Are you seeking guidance for NURS FPX 6218 Assessment 1? Our experts are ready to assist you. Contact us for support today.

Comparative Analysis of the Healthcare System

Accordingly, England, India, and the USA have broad overviews of managing ACD, identified from the determinants of the toxins or triggers that cause ACD, allergen avoidance, and patient satisfaction, as shown in Table 1 of the Appendix. These SCFs work hard to deliver the highest levels of care for ACD; by utilizing them, patients can better cope with the disease.

In light of the ongoing initiatives in the United States to deliver the best level of health care to its citizens, the forum finds it apposite to draw from systems practiced in England and India. If work on the individual and organizational level is carried out correctly, healthcare providers can reach the goal of concentrating on patients’ needs and providing good quality healthcare services. They can also improve the quality of the health with which their patients are being treated due to the better treatment.

Outcomes must be defined so that their achievement can be verified with high confidence. Outcomes should also be arranged in a logical and realistic sequence. The following sections will examine how these principles apply in practice. Outcomes must be designed in a way that is measurable and possible to achieve. How is this done? The following is the typical sequence of outcomes. Outcomes are sequential in an approach.

For this purpose, the amount of research information that can be accumulated from yearly patient records and self-completed surveys, including the number of patients who clinically recognize the toxins or triggers that cause ACD, the ability of patients to avoid allergens and patient satisfaction.

• Lessons Learned

Successful healthcare systems have been used in England, India, and the USA, including guideline formulation on the issue of triggers, Allergen avoidance education, and patient satisfaction interventions used in the control of ACD. Among the prospective conclusions that can be made based on these examples, the following possibilities are significant: National procedures should be developed or improved for ACD triggers; information focused on allergen avoidance should be available for the patients; and patient satisfaction schemes should be used. Learning from such principles in healthcare means the patient gains the best results, and the system does its best.

Financial and Health Implications

If implemented, the changes proposed could improve the outcomes of the ACD patient’s beneficiaries financially and in terms of health. The cost implications of managing the disease will decrease since implementing new changes may lead to the early identification of ACD patients, including the offering of patch testing. It should be noted that early condition identification helps avoid significant treatment expenditures needed to eliminate the disease manifestations, such as antihistamines or corticosteroids (Ahlström et al., 2019). This, in turn, leads to early detection. Thus, the patient can receive the proper treatment and cherish the chance to alter their lifestyle in minis, which may, in turn, enhance their quality of life and roll down the expenses of chronic treatments (Herman et al . , 2021).

On the other hand, failure to implement the proposed changes could be financially and healthwise unproductive and costly. ACD, if untreated or diagnosed early but left untreated, could worsen to a stage where first-line treatment is insufficient, and a more intensive form of therapy, like the administration of oral or intravenous steroids, may be needed. This might lead to significant expenses for the individual and the healthcare system. Moreover, early diagnosis is still absent, which might result in a lower quality of life for the patient since the disease progresses and can endanger work and basic daily living. A survey that was carried out in the United States of America revealed that offering some form of access to patch testing went a long way in significantly bringing down the expenses of managing ACD (Goldenberg et al., 2020). Further, the symptoms experienced by the people who did the patch testing were much lower, and their quality of life was much better than those who could not afford the test.

Conclusion

The changes proposed to improve the overall health status of those with ACD can, therefore, impact the financial and health aspects. From the above evidence, such changes may lead to the following benefits: they will be cheaper than the current system, and the mental health of candidates with ACD will improve. Some strategies adopted by the UK, India, and the United States are the outbreak of strategies to enhance early detection of ACD, identification of allergens and toxins, and facilities to assist patients with the disease. However, These strategies have been identified as effective in cutting costs commonly associated with treating ACD and enhancing patient satisfaction. Hence, expecting to make the changes that will help to obtain a higher quality of healthcare for the patients diagnosed with ACD can have the potential for financial and, mainly, health improvement.